Medscape InDiscussion: Myelofibrosis
Episodes
S2 Episode 6: A Futuristic Vision for Treating Myelofibrosis
10 Jul 2025
Contributed by Lukas
What will the next decade bring for myelofibrosis care? Drs Jain and Pemmaraju explore futuristic therapies, earlier interventions, and smarter diagno...
S2 Episode 5: Posttransplant Monitoring in Myelofibrosis
10 Jun 2025
Contributed by Lukas
Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and patient-centered transplant decisions ...
S2 Episode 4: JAK Inhibitors: Too Many Choices or Not Enough?
08 May 2025
Contributed by Lukas
Join Drs Tania Jain and Prithviraj Bose as they discuss the available JAK inhibitors and how they use them to treat myelofibrosis. Relevant disclosure...
S2 Episode 3: Can We Prevent Myelofibrosis? The New Interferon Era
08 Apr 2025
Contributed by Lukas
Join Drs Tania Jain and Brandi Reeves as they discuss primary myelofibrosis and post-ET (essential thrombocythemia) and post-PV (polycythemia vera) my...
S2 Episode 2: Diet, Exercise, and Myelofibrosis: A Holistic Approach
06 Mar 2025
Contributed by Lukas
Join Drs Tania Jain and Krisstina Gowin as they discuss the role integrative medicine plays in the treatment of myelofibrosis. Relevant disclosures ca...
S2 Episode 1: What's Next? Clinical Trials in Myelofibrosis
06 Mar 2025
Contributed by Lukas
Drs Tania Jain and Ruben Mesa discuss the clinical trials and the future of myelofibrosis research. Relevant disclosures can be found with the episode...
S1 Episode 6: What Does the Future Look Like for Myelofibrosis?
06 Nov 2024
Contributed by Lukas
Join Drs Tania Jain and Gabriela Hobbs as they discuss their views on the future of research and patient care in myelofibrosis. Relevant disclosures c...
S1 Episode 5: Transplant Tips, Talks, and Timing for Myelofibrosis
03 Oct 2024
Contributed by Lukas
Join Drs Tania Jain and Jeanne Palmer as they discuss their approach to transplant in myelofibrosis. Relevant disclosures can be found with the episod...
S1 Episode 4: Myelofibrosis: Considering TP53 and Post-MPN AML
05 Sep 2024
Contributed by Lukas
Join Drs Tania Jain and Raajit Rampal as they discuss TP53, post-MPN AML, and high-risk MPNs in the context of myelofibrosis. Relevant disclosures can...
S1 Episode 3: What's Your Approach? Treating Myelofibrosis
07 Aug 2024
Contributed by Lukas
Join Drs Tania Jain and Lindsay Rein as they discuss the current treatment landscape and their approach to treating patients with myelofibrosis. Relev...
S1 Episode 2: What's Next? Promising Trials and Therapeutics in Myelofibrosis
03 Jul 2024
Contributed by Lukas
Join Drs Tania Jain and Aaron Gerds as they discuss the latest developments in clinical trials and investigational therapeutics for MPNs. Relevant dis...
S1 Episode 1: Risk Stratification in Myelofibrosis: Which Model Should You Use?
03 Jul 2024
Contributed by Lukas
Join Drs Tania Jain and Pankit Vachhani as they discuss the nuance involved in the risk stratification of myelofibrosis and the latest research in pre...